1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Freedonia Focus on Pharmaceuticals: United States

Freedonia Focus on Pharmaceuticals: United States

  • May 2014
  • -
  • Freedonia Focus
  • -
  • 27 pages

This report forecasts US pharmaceutical (prescription and over-the-counter) shipments and demand in US dollars at the manufacturers' level to 2018. Total shipments are segmented by therapeutic class in terms of hormones and related, central nervous system, anti-infective, respiratory, cardiovascular, nutritional, gastrointestinal and genito-urinary, dermatological, and other pharmaceuticals.

To illustrate historical trends, total demand and shipments are provided in annual series from 2003 to 2013; the various shipments segments are reported at five-year intervals for 2008 and 2013. An Industry Overview section defines therapeutic classes, discusses market drivers and constraints, identifies substitute products when applicable, and provides pertinent background on ethical versus over-the-counter (OTC) pharmaceuticals, generic versus proprietary types, and trade.

An Industry Forecasts section assesses the impact of key drivers and constraints on each therapeutic class segment over the forecast period.

Further analysis includes an Industry Structure section, which surveys the supply base and profiles the leading firms competing in the US industry. A one-page, introductory Highlights section summarizes key findings from this 27-page report, and a Resources section lists contributing sources as well as resources available for further research.

Table Of Contents

Freedonia Focus on Pharmaceuticals: United States
HIGHLIGHTS

INDUSTRY OVERVIEW
Industry Size and Trends
Product Segmentation
Ethical vs Over-the-Counter
Generic vs Proprietary
Trade

INDUSTRY FORECASTS
Market Environment
Product Forecasts

INDUSTRY STRUCTURE
Industry Composition and Characteristics
Additional Companies Cited

RESOURCES

LIST OF TABLES AND CHARTS

Chart 1 | United States: Pharmaceutical Shipment Trends, 2003-2013
Chart 2 | United States: Pharmaceutical Demand Trends, 2003-2013
Chart 3 | United States: Pharmaceutical Shipments by Therapeutic Class, 2013
Chart 4 | United States: Pharmaceutical Shipments by Regulatory Class, 2013
Chart 5 | United States: Pharmaceutical Shipments by Patent Status, 2013
Chart 6 | United States: Pharmaceutical Trade, 2003-2013
Table 1 | United States: Key Indicators for Pharmaceutical Shipments; 2008, 2013, 2018 (US$ bil)
Table 2 | US: Pharmaceutical Shipments by Therapeutic Class; 2008, 2013, 2018 (US$ bil)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.